McKesson Revenue 2010-2023 | MCK

McKesson annual/quarterly revenue history and growth rate from 2010 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • McKesson revenue for the quarter ending December 31, 2023 was $80.898B, a 14.77% increase year-over-year.
  • McKesson revenue for the twelve months ending December 31, 2023 was $301.506B, a 10.08% increase year-over-year.
  • McKesson annual revenue for 2023 was $276.711B, a 4.83% increase from 2022.
  • McKesson annual revenue for 2022 was $263.966B, a 10.8% increase from 2021.
  • McKesson annual revenue for 2021 was $238.228B, a 3.11% increase from 2020.
McKesson Annual Revenue
(Millions of US $)
2023 $276,711
2022 $263,966
2021 $238,228
2020 $231,051
2019 $214,319
2018 $208,357
2017 $198,533
2016 $190,884
2015 $179,045
2014 $137,392
2013 $122,196
2012 $122,321
2011 $112,084
2010 $108,702
2009 $106,632
McKesson Quarterly Revenue
(Millions of US $)
2023-12-31 $80,898
2023-09-30 $77,215
2023-06-30 $74,483
2023-03-31 $68,910
2022-12-31 $70,490
2022-09-30 $70,157
2022-06-30 $67,154
2022-03-31 $66,102
2021-12-31 $68,614
2021-09-30 $66,576
2021-06-30 $62,674
2021-03-31 $59,142
2020-12-31 $62,599
2020-09-30 $60,808
2020-06-30 $55,679
2020-03-31 $58,535
2019-12-31 $59,172
2019-09-30 $57,616
2019-06-30 $55,728
2019-03-31 $52,429
2018-12-31 $56,208
2018-09-30 $53,075
2018-06-30 $52,607
2018-03-31 $51,628
2017-12-31 $53,617
2017-09-30 $52,061
2017-06-30 $51,051
2017-03-31 $48,713
2016-12-31 $50,130
2016-09-30 $49,957
2016-06-30 $49,733
2016-03-31 $46,678
2015-12-31 $47,899
2015-09-30 $48,761
2015-06-30 $47,546
2015-03-31 $44,925
2014-12-31 $46,484
2014-09-30 $44,160
2014-06-30 $43,476
2014-03-31 $37,832
2013-12-31 $34,336
2013-09-30 $32,985
2013-06-30 $32,239
2013-03-31 $30,643
2012-12-31 $31,099
2012-09-30 $29,755
2012-06-30 $30,699
2012-03-31 $31,286
2011-12-31 $30,839
2011-09-30 $30,216
2011-06-30 $29,980
2011-03-31 $28,853
2010-12-31 $28,247
2010-09-30 $27,534
2010-06-30 $27,450
2010-03-31 $26,643
2009-12-31 $28,272
2009-09-30 $27,130
2009-06-30 $26,657
2009-03-31 $26,224
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $69.909B $276.711B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $67.707B 19.66
West Pharmaceutical Services (WST) United States $28.565B 48.29
Cardinal Health (CAH) United States $25.143B 15.11
Align Technology (ALGN) United States $23.470B 47.33
Cooper (COO) United States $18.222B 27.57
Labcorp (LH) United States $17.496B 14.94
Henry Schein (HSIC) United States $9.348B 16.17
DENTSPLY SIRONA (XRAY) United States $6.399B 16.86
Merit Medical Systems (MMSI) United States $4.307B 24.65
STAAR Surgical (STAA) United States $2.355B 74.14
Patterson (PDCO) United States $2.327B 11.15
CONMED (CNMD) United States $2.196B 20.67
Atrion (ATRI) United States $0.713B 36.74
Lifevantage (LFVN) United States $0.082B 13.34
Pro-Dex (PDEX) United States $0.066B 25.00
Biolase (BIOL) United States $0.005B 0.00